Ionis Pharmaceuticals, Inc. (LON:0JDI)
London · Delayed Price · Currency is GBP · Price in USD 77.60
-0.92 (-1.17%)
Dec 19, 2025, 6:38 AM BST
Ionis Pharmaceuticals Employees
Ionis Pharmaceuticals had 1,069 employees as of December 31, 2024. The number of employees increased by 142 or 15.32% compared to the previous year.
Employees
1,069
Change (1Y)
142
Growth (1Y)
15.32%
Revenue / Employee
672.93K GBP
Profits / Employee
-178.39K GBP
Market Cap
9.32B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,069 | 142 | 15.32% |
| Dec 31, 2023 | 927 | 131 | 16.46% |
| Dec 31, 2022 | 796 | 136 | 20.61% |
| Dec 31, 2021 | 660 | -97 | -12.81% |
| Dec 31, 2020 | 757 | -60 | -7.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| Convatec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| Genus | 3,190 |
| HUTCHMED (China) | 1,811 |
Ionis Pharmaceuticals News
- 3 days ago - Ionis Pharmaceuticals (IONS): Leerink Partners Raises Price Target | IONS Stock News - GuruFocus
- 9 days ago - Ionis Pharmaceuticals (IONS) Price Target Raised by B of A Securities | IONS Stock News - GuruFocus
- 9 days ago - Ionis Pharmaceuticals, Inc. (IONS) Presents at The 67th American Society of Hematology (ASH) Annual Meeting - Slideshow - Seeking Alpha
- 16 days ago - Ionis Pharmaceuticals (IONS) Gains FDA Breakthrough Therapy Designation - GuruFocus
- 16 days ago - Ionis Pharma: FDA Grants Breakthrough Therapy Designation To Zilganersen - Nasdaq
- 16 days ago - FDA Grants Breakthrough Therapy Status to Ionis Pharmaceuticals' Zilganersen (IONS) - GuruFocus
- 16 days ago - Ionis receives U.S. FDA Breakthrough Therapy designation for zilganersen for Alexander disease (AxD) - Business Wire
- 17 days ago - Ionis Wins FDA Breakthrough Therapy Designation For Olezarsen In Severe Hypertriglyceridemia - Nasdaq